Earth Science Tech (ETST) Operating Income (2011 - 2026)
Earth Science Tech's (ETST) quarterly Operating Income came in at $577801.0 in Q2 2026, up 139.13% on a YoY basis from $241631.0 in Q2 2025, and down 49.42% quarter-over-quarter from $1.1 million in Q1 2026.
Analysis
Earth Science Tech (ETST) Operating Income (2011 - 2026) Analysis & Trends
Earth Science Tech (ETST) has reported Operating Income for 15 consecutive years, with $577801.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Operating Income rose 139.13% year-over-year to $577801.0; the trailing twelve-month figure through Jun 2026 stood at $3.6 million (up 38.87% YoY), and the FY2026 full-year result was $3.3 million, down 4.04% from the prior year.
- Operating Income fell to $577801.0 in Q2 2026 per ETST's latest filing, from $1.1 million in the prior quarter.
- Across five years, Operating Income topped out at $1.3 million in Q4 2025 and bottomed at -$692172.0 in Q2 2022.
- Historically, Operating Income has averaged $404231.1 across 5 years, with a median of $250058.0 in 2024.
- The sharpest annual moves came in 2022 and 2024: Operating Income tumbled 5896.98% in 2022, then surged 4734.95% in 2024.
- Over 5 years, Operating Income stood at -$48275.0 in 2022, then jumped by 578.57% to $231031.0 in 2023, then fell by 2.08% to $226226.0 in 2024, then surged by 493.22% to $1.3 million in 2025, then slumped by 56.95% to $577801.0 in 2026.
- According to Business Quant data, Operating Income over the past three periods registered $577801.0, $1.1 million, and $1.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.61 Bn | 38.95 Bn | 2.15 Bn | -231.00 Mn |
| 2 | Viatris | 19.18 Bn | 18.30 Bn | 1.46 Bn | 6.30 Mn |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn | 39.97 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | 129.77 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 518.87 Mn | 2.10 Bn | 740.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -73.42 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 40.46 Mn |
| 8 | Amphastar Pharmaceuticals | 994.21 Mn | 704.09 Mn | 93.47 Mn | 39.73 Mn |
| 9 | Fennec Pharmaceuticals | 405.56 Mn | 364.31 Mn | 17.15 Mn | 1.74 Mn |
| 10 | Earth Science Tech | 25.88 Mn | 23.09 Mn | 6.28 Mn | 577,801.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 577,801.00 |
| Mar 31, 2026 | 1.14 Mn |
| Dec 31, 2025 | 1.34 Mn |
| Sep 30, 2025 | 582,618.00 |
| Jun 30, 2025 | 241,631.00 |
| Mar 31, 2025 | 1.33 Mn |
| Dec 31, 2024 | 226,226.00 |
| Sep 30, 2024 | 829,560.00 |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 258,485.00 |
| Dec 31, 2023 | 231,031.00 |
| Sep 30, 2023 | 479,944.00 |
| Jun 30, 2023 | -22,978.00 |
| Mar 31, 2023 | -119,323.00 |
| Dec 31, 2022 | -48,275.00 |
| Sep 30, 2022 | -76,913.00 |
| Jun 30, 2022 | -692,172.00 |
| Mar 31, 2022 | -68,023.00 |
| Dec 31, 2021 | -100,951.00 |
| Sep 30, 2021 | -46,190.00 |